z-logo
open-access-imgOpen Access
Vesicular monoamine transporter 2 mediates fear behavior in mice
Author(s) -
Branco Rachel C.,
Burkett James P.,
Black Carlie A.,
Winokur Emily,
Ellsworth William,
Dhamsania Rohan K.,
Lohr Kelly M.,
Schroeder Jason P.,
Weinshenker David,
Jovanovic Tanja,
Miller Gary W.
Publication year - 2020
Publication title -
genes, brain and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.315
H-Index - 91
eISSN - 1601-183X
pISSN - 1601-1848
DOI - 10.1111/gbb.12634
Subject(s) - monoamine neurotransmitter , vesicular monoamine transporter 2 , monoaminergic , vesicular monoamine transporter , dopamine , psychology , anxiogenic , fear conditioning , neuroscience , striatum , neurochemical , amygdala , biology , serotonin , dopamine transporter , anxiety , dopaminergic , psychiatry , genetics , receptor , anxiolytic
A subset of people exposed to a traumatic event develops post‐traumatic stress disorder (PTSD), which is associated with dysregulated fear behavior. Genetic variation in SLC18A2 , the gene that encodes vesicular monoamine transporter 2 (VMAT2), has been reported to affect risk for the development of PTSD in humans. Here, we use transgenic mice that express either 5% (VMAT2‐LO mice) or 200% (VMAT2‐HI mice) of wild‐type levels of VMAT2 protein. We report that VMAT2‐LO mice have reduced VMAT2 protein in the hippocampus and amygdala, impaired monoaminergic vesicular storage capacity in both the striatum and frontal cortex, decreased monoamine metabolite abundance and a greatly reduced capacity to release dopamine upon stimulation. Furthermore, VMAT2‐LO mice showed exaggerated cued and contextual fear expression, altered fear habituation, inability to discriminate threat from safety cues, altered startle response compared with wild‐type mice and an anxiogenic‐like phenotype, but displayed no deficits in social function. By contrast, VMAT2‐HI mice exhibited increased VMAT2 protein throughout the brain, higher vesicular storage capacity and greater dopamine release upon stimulation compared with wild‐type controls. Behaviorally, VMAT2‐HI mice were similar to wild‐type mice in most assays, with some evidence of a reduced anxiety‐like responses. Together, these data show that presynaptic monoamine function mediates PTSD‐like outcomes in our mouse model, and suggest a causal link between reduced VMAT2 expression and fear behavior, consistent with the correlational relationship between VMAT2 genotype and PTSD risk in humans. Targeting this system is a potential strategy for the development of pharmacotherapies for disorders like PTSD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here